NEW YORK, February 05, 2025--(BUSINESS WIRE)--Radformation Inc., a global pioneer in radiation oncology software solutions, is proud to announce that AutoContour, ClearCheck, ClearCalc, and ChartCheck ...
NEW YORK, September 29, 2025--(BUSINESS WIRE)--Radformation Inc, a leading provider of intelligent automation solutions for radiation oncology, today announced a new collaboration with Icon Group, a ...
NEW YORK, May 18, 2021 /PRNewswire/ — Radformation, the leader in radiation oncology automation, has hired Joe Ianni as Chief Revenue Officer, where he will play a pivotal role in Radformation’s ...
NEW YORK--(BUSINESS WIRE)--Radformation, a leader in cancer care clinical and operational software solutions, announced today that BVP Forge has made a strategic investment in the company to ...
Kurt Sysock's journey into entrepreneurship began while he was working as a medical physicist in a clinic. While creating radiation treatment plans, he recognized that the process for oncology ...
NEW YORK — Radformation, Inc., a leader in automation solutions for cancer care, announced today that it has acquired privately-held Limbus AI, a leading global provider of automated contouring ...
NEW YORK & BRISBANE, Australia–(BUSINESS WIRE)–Radformation, a global pioneer in radiation oncology software solutions, is pleased to announce its strategic partnership with Icon Group (Icon), a ...
ChartCheck Adaptive brings quantitative insight into daily radiotherapy dose and anatomy changes. Radformation, a leading provider of intelligent automation solutions for radiation oncology, and Icon ...
Today the world's most successful mudblood can finally have a quarter-life crisis. Daniel Radcliffe has been in the public eye for 13 years now, and over that time he has changed drastically. With all ...
Today, we're delving into the fascinating world of radiation oncology and the critical role technology plays in patient care. Our guest, Kurt Sysock, co-founder and CEO of Radformation, has a solution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results